Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
BMC Cancer|May 22, 2023
Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC)Linde Kehmann, Marie-Luise Berres, Maria Gonzalez-Carmona, et al.
Cancers|November 9, 2024
Extracellular Vesicles May Predict Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular CarcinomaMara Egerer, Kathrin Schuch, David Schöler, et al.
Cellular and Molecular Gastroenterology and Hepatology|July 5, 2022
Cell-specific Deletion of NLRP3 Inflammasome Identifies Myeloid Cells as Key Drivers of Liver Inflammation and Fibrosis in Murine SteatohepatitisBenedikt Kaufmann, Lin Kui, Agustina Reca, et al.
Journal of Clinical Medicine|June 4, 2020
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations are Elevated in Patients with Neuroendocrine MalignanciesBurcin Özdirik, Anna Stueven, Jana Knorr, et al.
Clinical Science (London, England : 1979)|May 1, 2013
Fetuin-A mRNA expression is elevated in NASH compared with NAFL patientsAlisan Kahraman, Jan-Peter Sowa, Martin Schlattjan, et al.
Digestion|December 23, 2014
Mini-laparoscopy guided liver biopsy increases diagnostic accuracy in acute liver failureAlexander Dechêne, Jan-Peter Sowa, Martin Schlattjan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 19, 2025
Development of Liver-Heart Score for Early Detection of Myocardial Contractile Dysfunction in Cirrhosis by Strain ImagingMarcel Razpotnik, Simona Bota, Philipp Wimmer, et al.
Journal of Clinical Medicine|October 27, 2022
Inflammatory Cytokines Associated with Diagnosis, Tumor Grade and Prognosis in Patients with Neuroendocrine TumorsLukas Geisler, Teresa Hellberg, Joeri Lambrecht, et al.
Hepatology (Baltimore, Md.)|January 8, 2022
NOD-like receptor protein 3 activation causes spontaneous inflammation and fibrosis that mimics human NASHDavid M Calcagno, Angela Chu, Susanne Gaul, et al.
Hepatology (Baltimore, Md.)|September 14, 2017
NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL-17 and TNF in miceAlexander Wree, Matthew D McGeough, Maria Eugenia Inzaugarat, et al.
Pageof 8